1 / 18

DOPAMIN

DOPAMIN. A dopaminerg neurotranszmisszio egyszeru semaja. A dopaminerg axon terminalis.

jereni
Download Presentation

DOPAMIN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DOPAMIN

  2. A dopaminerg neurotranszmisszio egyszeru semaja

  3. A dopaminerg axon terminalis Left picture shows rich presence of dopamine-containing nerve endings (green dots) in the basal ganglia of a rat brain, visualized by fluorescence microscopy. To the right, a close-up of one nerve ending as seen in the electron microscope. The black dots in the vesicles represent stored dopamine.

  4. A dopamin receptorok szignaltranszdukcioja

  5. Az adenil-ciklázt befolyasolo dopamin receptorok (D1, D5, D2)

  6. Dopamin metabolitok Agytörzsi magvak Limbikus kéreg Nigro-striatalis pályák! HOMOVANILINSAV: Szintje a dopaminerg neuronok funkcionális állapotara utal Parkinson kór â Schizophrenia á

  7. A dopaminerg rendszer kóros működése következtében kialakuló betegségek: Parkinson kór Schizophrenia

  8. Dopaminergic pathways of the human brain in normal condition (left) and Parkinson's disease (right). Red Arrows indicate suppression of the target, blue arrows indicate stimulation of target structure.

  9. A Parkinson kór indukalasa *Cycad tree - trópusi gyom B-N-metil-amino-alanin (BMAA) *1-metil-4-phenyl-1,2,3,3-tetrahidropiridin (MPTP) iv. kábítószerrel (heroin-származék szintézise során keletkezik) A dopaminerg neuronok felveszik ↓MAO-B 1-metil-4-fenil pyridinium (MPP+) → toxikus *Complex I gatlok – (peszticidek, rotenon)

  10. A Parkinson kor terapiaja *L-DOPA (levodopa) Periferiás DOPA-dekarboxiláz aktivitasà1 % kerül az agyba Kombináció:Carbidopa (DOPA-dekarboxiláz gátló, agy-vér gáton nem jut át, csak a periferian gatol) * Dopamin receptor agonisták (schizophrenia!)

  11. Schizophrenia Egyik elképzelés: Centrális dopaminerg neuronok fokozott aktivitása Hatékony antipsychotikus szerek: Dopamin receptor gátlók – D2 receptor gatlo neuroleptikumok (Parkinson kór alakulhat ki!) • Dopamin szint az agyban emelkedett • Homovanilinsav szint a liquorban emelkedett • D2 receptorok száma megnőtt USA lakosság 1 %-a érintett Kórházi ágyak 25 %-at ilyen betegek foglalják el

  12. Some properties of dopamine receptors. New receptors, isolated using appropriate probes and genomic or cDNA libraries, are being reported frequently • At least five different major classes are recognized (D1-D5), with some subtypes formed by alternative splicing. • They are membrane proteins, at least some of which are glycosylated. • Most have seven transmembrane domains with cytoplasmic loops. • Most appear to be coupled to G proteins. • Some are positively coupled to adenylyl cyclase (eg, D1), • at least one (D2) negatively. • At least one subtype (of D1) appears to be coupled to phospholipase C.

  13. Some properties of dopamine receptors. New receptors, isolated using appropriate probes and genomic or cDNA libraries, are being reported frequently • Five distinct subtypes of the D4 receptor have been recognized, it being the first member of the catecholaminefamily of receptors to show polymorphic variation in the human population. Based on Strange PG: Interesting times for dopamine receptors. Trends Neurol Sci 1991;14:43, and Iversen L: Which D4 do you have? Nature 1992;358:109.

  14. Some properties of dopamine receptors. New receptors, isolated using appropriate probes and genomic or cDNA libraries, are being reported frequently • Some, at least, are regulated by phosphorylation. • Drug affinities of most neuroleptics for the D2 receptor reflect their potencies in treating schizophrenia. • The various receptors show different anatomic distributions. • The D4 receptor binds the atypical neuroleptic clozapine with an affinity ten times higher than that of D2 sites.

More Related